Clinical Research Focus 20th Edition September | Cromos Pharma
Clinical Research Focus. 20th Edition After Receiving First GMO Clinical Trial Approval in Georgia, Cromos Pharma Reflects on Complex International Regulatory Landscape for GMO Research Cromos Pharma has received the groundbreaking approval to conduct the first Genetically Modified Organism (GMO) clinical trial in Georgia. This pioneering accomplishment not only underscores the company’s commitment to scientific advancement but also prompts a Read more
EMA Releases a Reflection Paper on the Role of AI in Drug Development
EMA Releases a Reflection Paper on the Role of AI in Drug Development The European Medicines Agency (EMA) has released a reflection paper outlining its thoughts on integrating artificial intelligence (AI) in supporting the progression, oversight, and utilization of human and veterinary medicines. This document covers AI’s application from drug discovery to post-authorization. Part of the HMA-EMA Big Data Steering Group’s efforts, this paper is a collaborative endeavor Read more
Regulatory Landscapes of GMO Research Programs | Cromos Pharma
Cromos Pharma Contemplates Complex International GMO Research Program Regulations Cromos Pharma has received the groundbreaking approval to conduct the first Genetically Modified Organism (GMO) clinical trial. This pioneering accomplishment not only underscores the company’s commitment to scientific advancement but also prompts a comprehensive reflection of the intricate regulatory landscape governing GMO trials in the US and EU. Initiating the first GMO clinical trial in Read more
Decentralized Clinical Trials | Cromos Pharma
Decentralized Clinical Trials: Balancing the Promise and Pitfalls in Cost, Recruitment, and Patient Satisfaction Decentralized clinical trials (DCTs) have emerged as a transformative solution in clinical research, leveraging remote technologies to streamline processes, boost patient satisfaction, and expedite recruitment. However, the potential pitfalls of increased costs and compromised recruitment and patient satisfaction warrant careful consideration by biotech professionals. This synthesis delves into the complex landscape of DCTs, addressing both Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us